← Back to all trials
Active Not Recruiting
NCT06935071
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
Conditions: Hip Fractures, Hip Fracture Pathologic, Pathological Fracture, Pathological Fracture of Hip
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 300
Sponsor: Memorial Sloan Kettering Cancer Center
Location: Memorial Sloan Kettering Cancer Center New York New York
Summary
This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of ambulation in the current population.
Eligibility Criteria
Inclusion Criteria:
* Participants have received endoprosthetic reconstruction for pathologic fracture of the proximal femur
Exclusion Criteria:
* Participants with fractures greater than 3mm from the lesser trochanter
* Participants without histopathologic confirmation of tumor
Source: ClinicalTrials.gov (NCT06935071). StuddyBuddy aggregates publicly available trial information.
